Roivant Sciences Ltd.
USD34.07
+0.05 (+0.15%)
CEO
Matthew Gline
IPO Date
2020-12-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
GB
Open
$34.05
Prev. Close
$34.02
Day Low
$33.72
Day High
$34.45
52W Low
$10.71
52W High
$34.68
Market Cap
$24.51B
Volume
12.41M
| 153,766 |
| $33.05 |
| 26 Jun 2026 | Venker Eric | President & Immunovant CEO | S-Sale | Disposed | 46,234 | $33.51 |
| 26 Jun 2026 | Venker Eric | President & Immunovant CEO | M-Exempt | Disposed | 200,000 | $3.85 |
| 23 Jun 2026 | Pulik Richard | CFO | F-InKind | Disposed | 2,129 | $31.43 |
| 23 Jun 2026 | Humes Jennifer | Chief Accounting Officer | F-InKind | Disposed | 3,582 | $31.43 |
| 22 May 2026 | Venker Eric | President & Immunovant CEO | F-InKind | Disposed | 34,483 | $32.41 |
| 22 May 2026 | Venker Eric | President & Immunovant CEO | M-Exempt | Acquired | 200,000 | $3.85 |
| 22 May 2026 | Venker Eric | President & Immunovant CEO | S-Sale | Disposed | 200,000 | $30.27 |
| 22 May 2026 | Venker Eric | President & Immunovant CEO | M-Exempt | Disposed | 200,000 | $3.85 |